Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2012 1
2013 1
2014 1
2015 2
2017 2
2018 3
2019 4
2020 10
2021 15
2022 9
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS.
Loosen SH, Benz F, Mohr R, Reuken PA, Wirtz TH, Junker L, Jansen C, Meyer C, Praktiknjo M, Wree A, Reißing J, Demir M, Gu W, Vucur M, Schierwagen R, Stallmach A, Kunstein A, Bode J, Trautwein C, Tacke F, Luedde T, Bruns T, Trebicka J, Roderburg C. Loosen SH, et al. Among authors: mohr r. JHEP Rep. 2024 Mar 4;6(5):101054. doi: 10.1016/j.jhepr.2024.101054. eCollection 2024 May. JHEP Rep. 2024. PMID: 38681861 Free PMC article.
Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study.
Chalkias A, Huang Y, Ismail A, Pantazopoulos I, Papagiannakis N, Bitterman B, Anderson E, Catalan T, Erne GK, Tilley CR, Alaka A, Amadi KM, Presswalla F, Blakely P, Bernal-Morell E, Cebreiros López I, Eugen-Olsen J, García de Guadiana Romualdo L, Giamarellos-Bourboulis EJ, Loosen SH, Reiser J, Tacke F, Skoulakis A, Laou E, Banerjee M, Pop-Busui R, Hayek SS; International Study of Inflammation in COVID-19 (ISIC) Investigator Group. Chalkias A, et al. Crit Care Med. 2024 Feb 23. doi: 10.1097/CCM.0000000000006229. Online ahead of print. Crit Care Med. 2024. PMID: 38391282
Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.
Müller-Jensen L, Knauss S, Ginesta Roque L, Schinke C, Maierhof SK, Bartels F, Finke C, Rentzsch K, Ulrich C, Mohr R, Stenzel W, Endres M, Boehmerle W, Huehnchen P. Müller-Jensen L, et al. Among authors: mohr r. Data Brief. 2024 Jan 18;53:110062. doi: 10.1016/j.dib.2024.110062. eCollection 2024 Apr. Data Brief. 2024. PMID: 38317734 Free PMC article.
Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational research.
Saqr AA, Kamali C, Brunnbauer P, Haep N, Koch P, Hillebrandt KH, Keshi E, Moosburner S, Mohr R, Raschzok N, Pratschke J, Krenzien F. Saqr AA, et al. Among authors: mohr r. Front Med (Lausanne). 2024 Jan 8;10:1278641. doi: 10.3389/fmed.2023.1278641. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38259852 Free PMC article.
Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.
Müller-Jensen L, Schulz AR, Mei HE, Mohr R, Ulrich C, Knape P, Frost N, Frischbutter S, Kunkel D, Schinke C, Ginesta Roque L, Maierhof SK, Nickel FT, Heinzerling L, Endres M, Boehmerle W, Huehnchen P, Knauss S. Müller-Jensen L, et al. Among authors: mohr r. Neuro Oncol. 2024 Feb 2;26(2):279-294. doi: 10.1093/neuonc/noad198. Neuro Oncol. 2024. PMID: 37823709
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN).
Krieg S, Tunk J, Vaghiri S, Prassas D, Jann H, Mohr R, Loosen SH, Roderburg C, Maasberg S, Begum N, Luedde T, Schott M, Giesel F, Knoefel WT, Krieg A; and the members of the German NET Registry. Krieg S, et al. Among authors: mohr r. Horm Metab Res. 2023 Jul;55(7):452-461. doi: 10.1055/a-2102-7694. Epub 2023 Jul 10. Horm Metab Res. 2023. PMID: 37494059 Free PMC article.
69 results